Off‐Label Use of Ketamine: A Challenging Drug Treatment Delivery Model With an Inherently Unfavorable Risk‐Benefit Profile
Crossref DOI link: https://doi.org/10.1002/jcph.1983
Published Online: 2021-12-02
Published Print: 2022-01
Update policy: https://doi.org/10.1002/crossmark_policy
Pai, Sudhakar M. https://orcid.org/0000-0001-8091-546X
Gries, Jean‐Michel
,
Version of Record valid from 2021-12-02
Publication History
Received: 2021-10-05
Accepted: 2021-10-08
Published: 2021-12-02
